Xiaofang Xing

4.3k total citations
60 papers, 1.3k citations indexed

About

Xiaofang Xing is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaofang Xing has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 20 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaofang Xing's work include Gastric Cancer Management and Outcomes (12 papers), Protein Tyrosine Phosphatases (9 papers) and Galectins and Cancer Biology (8 papers). Xiaofang Xing is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Protein Tyrosine Phosphatases (9 papers) and Galectins and Cancer Biology (8 papers). Xiaofang Xing collaborates with scholars based in China, Ethiopia and United States. Xiaofang Xing's co-authors include Jiafu Ji, Hong Du, Ting Guo, Xiaojing Cheng, Chengchao Shou, Ying Hu, Xianzi Wen, Like Qu, Bin Dong and Ziyu Li and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xiaofang Xing

59 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofang Xing China 23 901 370 309 214 209 60 1.3k
Kun-Tu Yeh Taiwan 23 866 1.0× 346 0.9× 438 1.4× 127 0.6× 184 0.9× 43 1.4k
Fabiana Conciatori Italy 17 743 0.8× 309 0.8× 463 1.5× 184 0.9× 179 0.9× 23 1.2k
Mingo M. H. Yung Hong Kong 18 874 1.0× 566 1.5× 293 0.9× 222 1.0× 245 1.2× 23 1.3k
Yefei Rong China 20 719 0.8× 469 1.3× 509 1.6× 256 1.2× 104 0.5× 41 1.3k
Haluk Yuzugullu France 10 1.4k 1.5× 305 0.8× 541 1.8× 154 0.7× 307 1.5× 12 1.8k
Wenhua Lang United States 17 784 0.9× 257 0.7× 374 1.2× 124 0.6× 304 1.5× 28 1.3k
Yansu Chen China 20 664 0.7× 312 0.8× 349 1.1× 124 0.6× 120 0.6× 39 1.0k
Ti Wen China 24 638 0.7× 319 0.9× 521 1.7× 391 1.8× 146 0.7× 48 1.2k
Zhenjia Yu China 12 415 0.5× 285 0.8× 362 1.2× 212 1.0× 198 0.9× 20 896
Stacey M. Bagby United States 21 568 0.6× 242 0.7× 516 1.7× 194 0.9× 158 0.8× 62 1.1k

Countries citing papers authored by Xiaofang Xing

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Xing more than expected).

Fields of papers citing papers by Xiaofang Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Xing. The network helps show where Xiaofang Xing may publish in the future.

Co-authorship network of co-authors of Xiaofang Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Xing. A scholar is included among the top collaborators of Xiaofang Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Xing. Xiaofang Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Ting, Xiaofang Xing, Yingai Li, et al.. (2025). The accumulation of myeloid‐derived suppressor cells participates in abdominal infection‐induced tumor progression through the PD ‐ L 1/ PD ‐1 axis. Molecular Oncology. 19(5). 1532–1545. 1 indexed citations
2.
Patel, Rima, Jami Fukui, Paula Klein, et al.. (2025). Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer. Breast Cancer Research and Treatment. 214(2). 159–170.
3.
Wang, Yuqin, Hui Hui, Jing Han, et al.. (2025). A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer. Advanced Science. 12(16). e2413913–e2413913. 2 indexed citations
4.
Ma, Xiaoxiao, Shuqin Jia, Min Liang, et al.. (2023). TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduction and Targeted Therapy. 8(1). 246–246. 51 indexed citations
5.
Li, Lin, et al.. (2023). Death receptor 5 promotes tumor progression in gastric cancer. FEBS Open Bio. 13(12). 2375–2388. 2 indexed citations
6.
Deng, Ziqian, Ting Guo, Ying Hu, et al.. (2023). Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction. Journal of Translational Medicine. 21(1). 638–638. 4 indexed citations
7.
Huangfu, Longtao, et al.. (2023). T‐cells infiltration mediates the association between neutrophil/lymphocyte ratio and survival in gastric cancer. Cancer Medicine. 12(15). 15893–15902. 5 indexed citations
8.
Shen, Li, Yiding Wang, Hong Du, et al.. (2023). Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. International Journal of Molecular Sciences. 24(6). 5482–5482. 5 indexed citations
9.
Sun, Shuning, Xiaofang Xing, Ningning Li, et al.. (2023). Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma. Journal of Cancer. 14(13). 2585–2595. 3 indexed citations
10.
Han, Jing, Cong Chen, Xiaojing Cheng, et al.. (2022). SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis. Cancer Communications. 42(11). 1141–1161. 13 indexed citations
11.
Tang, Xiaohuan, Xiaolong Wu, Ting Guo, et al.. (2022). Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer. Frontiers in Oncology. 12. 808817–808817. 5 indexed citations
12.
Guo, Ting, Yanhua Bai, Xiaojing Cheng, et al.. (2021). Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. Cancer Communications. 41(3). 258–272. 28 indexed citations
13.
Huangfu, Longtao, Jing Han, Xiaomei Li, et al.. (2021). MicroRNA-135b/CAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling. International Journal of Biological Sciences. 17(8). 1940–1952. 17 indexed citations
14.
Du, Yang, Meng Cai, Xiaofang Xing, et al.. (2020). PINA 3.0: mining cancer interactome. Nucleic Acids Research. 49(D1). D1351–D1357. 39 indexed citations
15.
Xing, Xiaofang, Bin Dong, Xiaojing Cheng, et al.. (2018). Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer. Cancer Management and Research. Volume 10. 4969–4980. 19 indexed citations
16.
Yuan, Peng, Xiaojing Cheng, Xiaojiang Wu, et al.. (2016). OSMR and SEPT9: promising biomarkers for detection of colorectal cancer based on blood-based tests. Translational Cancer Research. 5(2). 131–139. 5 indexed citations
17.
Wang, Xiaohong, Hong Du, Li Lin, et al.. (2016). Increased expression of S100A6 promotes cell proliferation in gastric cancer cells. Oncology Letters. 13(1). 222–230. 24 indexed citations
18.
Xing, Xiaofang, Shenyi Lian, Ying Hu, et al.. (2013). Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Journal of Translational Medicine. 11(1). 309–309. 25 indexed citations
19.
Ren, Tingting, Beihai Jiang, Xiaofang Xing, et al.. (2009). Prognostic Significance of Phosphatase of Regenerating Liver-3 Expression in Ovarian Cancer. Pathology & Oncology Research. 15(4). 555–560. 49 indexed citations
20.
Xing, Xiaofang, Lirong Peng, Like Qu, et al.. (2009). Prognostic value of PRL‐3 overexpression in early stages of colonic cancer. Histopathology. 54(3). 309–318. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kun-Tu Yeh Breakdown of academic impact, for papers by Fabiana Conciatori Breakdown of academic impact, for papers by Mingo M. H. Yung Breakdown of academic impact, for papers by Yefei Rong Breakdown of academic impact, for papers by Haluk Yuzugullu Breakdown of academic impact, for papers by Wenhua Lang Breakdown of academic impact, for papers by Yansu Chen Breakdown of academic impact, for papers by Ti Wen Breakdown of academic impact, for papers by Zhenjia Yu Breakdown of academic impact, for papers by Stacey M. Bagby
Rankless by CCL
2026